{"name":"GBS Ventures","permalink":"gbs-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/gbs-ventures","homepage_url":"http://www.gbsventures.com.au","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"61-3-8650-9900 ","description":"Life science venture capital group","email_address":"investment@gbsventures.com.au","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Mon Jun 15 07:02:48 UTC 2009","updated_at":"Mon Jun 15 14:16:28 UTC 2009","overview":"<p>GBS Venture Partners (GBS) is a leading life science venture capital group resulting from a November 2002 management buyout of Rothschild Bioscience Managers Limited from NM Rothschild &amp; Sons (Aust) Ltd. </p>","image":{"available_sizes":[[[100,74],"assets/images/resized/0004/8580/48580v1-max-150x150.png"],[[100,74],"assets/images/resized/0004/8580/48580v1-max-250x250.png"],[[100,74],"assets/images/resized/0004/8580/48580v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"Harley House, Level 5","address2":"71 Collins Street, Melbourne Vic 3000","zip_code":"","city":"Melbourne","state_code":null,"country_code":"AUS","latitude":-37.985729,"longitude":145.138297}],"relationships":[{"is_past":false,"title":"","person":{"first_name":"Dr","last_name":"Geoff Brooke","permalink":"dr-geoff-brooke","image":{"available_sizes":[[[97,147],"assets/images/resized/0004/8581/48581v1-max-150x150.jpg"],[[97,147],"assets/images/resized/0004/8581/48581v1-max-250x250.jpg"],[[97,147],"assets/images/resized/0004/8581/48581v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"","person":{"first_name":"Andrew","last_name":"Baker","permalink":"andrew-baker","image":{"available_sizes":[[[97,147],"assets/images/resized/0004/8583/48583v1-max-150x150.jpg"],[[97,147],"assets/images/resized/0004/8583/48583v1-max-250x250.jpg"],[[97,147],"assets/images/resized/0004/8583/48583v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"","person":{"first_name":"Brigitte","last_name":"Smith","permalink":"brigitte-smith","image":{"available_sizes":[[[97,147],"assets/images/resized/0004/8582/48582v1-max-150x150.jpg"],[[97,147],"assets/images/resized/0004/8582/48582v1-max-250x250.jpg"],[[97,147],"assets/images/resized/0004/8582/48582v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"d","source_url":"http://www.kalobios.com/kb_news_2008_12_22.php","source_description":"KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":12,"funded_day":22,"company":{"name":"KaloBios Pharmaceuticals","permalink":"kalobios-pharmaceuticals","image":{"available_sizes":[[[150,42],"assets/images/resized/0004/8539/48539v1-max-150x150.jpg"],[[161,46],"assets/images/resized/0004/8539/48539v1-max-250x250.jpg"],[[161,46],"assets/images/resized/0004/8539/48539v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2008/05/16/novasys-medical-takes-495m-for-womens-medical-device/","source_description":"Novasys Medical takes $49.5M for womenâ€™s medical device","raised_amount":49500000,"raised_currency_code":"USD","funded_year":2008,"funded_month":5,"funded_day":16,"company":{"name":"NovaSys","permalink":"novasys","image":{"available_sizes":[[[150,48],"assets/images/resized/0005/2246/52246v1-max-150x150.png"],[[193,62],"assets/images/resized/0005/2246/52246v1-max-250x250.png"],[[193,62],"assets/images/resized/0005/2246/52246v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.phenomixcorp.com/news-07-03-08.asp","source_description":"PHENOMIX COMPLETES $55 MILLION SERIES C FINANCING","raised_amount":55000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":8,"company":{"name":"Phenomix","permalink":"phenomix","image":{"available_sizes":[[[150,34],"assets/images/resized/0007/9903/79903v1-max-150x150.jpg"],[[211,48],"assets/images/resized/0007/9903/79903v1-max-250x250.jpg"],[[211,48],"assets/images/resized/0007/9903/79903v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2010/03/17/nuon-captures-6-05m-to-develop-treatments-for-autoimmune-disease/","source_description":"Nuon captures $6.05M to develop treatments for autoimmune disease","raised_amount":6050000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":17,"company":{"name":"Nuon Therapeutics","permalink":"nuon-therapeutics","image":{"available_sizes":[[[150,55],"assets/images/resized/0005/1236/51236v1-max-150x150.jpg"],[[240,88],"assets/images/resized/0005/1236/51236v1-max-250x250.jpg"],[[240,88],"assets/images/resized/0005/1236/51236v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.xenome.com/v2/index.php?menu=news_full&id=91&year=news_2010","source_description":"Xenome Completes A$10M Convertible Note Financing: Ongoing Support from Existing Venture Capital Investors - 22 April 2010","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":22,"company":{"name":"Xenome","permalink":"xenome","image":{"available_sizes":[[[150,65],"assets/images/resized/0008/0338/80338v1-max-150x150.jpg"],[[206,90],"assets/images/resized/0008/0338/80338v1-max-250x250.jpg"],[[206,90],"assets/images/resized/0008/0338/80338v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.euthymics.com/pdf/2010.07.22%20Press%20Release%20-%20Euthymics%20Series%20A.pdf","source_description":"EUTHYMICS BIOSCIENCE, INC. CLOSES $24 MILLION SERIES A FINANCING AND COMPLETES ACQUISITION OF DOV PHARMACEUTICAL","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":22,"company":{"name":"Euthymics Bioscience","permalink":"euthymics-bioscience","image":{"available_sizes":[[[150,42],"assets/images/resized/0009/4756/94756v1-max-150x150.png"],[[221,62],"assets/images/resized/0009/4756/94756v1-max-250x250.png"],[[221,62],"assets/images/resized/0009/4756/94756v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.lifescientist.com.au/article/142987/opal_therapeutics_raises_6m_series_funding/","source_description":"Opal Therapeutics raises $6m in series A funding","raised_amount":6000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":10,"funded_day":31,"company":{"name":"OPAL Therapeutics","permalink":"opal-therapeutics","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://goliath.ecnext.com/coms2/gi_0199-4341658/Hatchtech-gets-funding-for-head.html","source_description":"Hatchtech gets funding for head lice therapy.","raised_amount":2200000,"raised_currency_code":"USD","funded_year":2005,"funded_month":5,"funded_day":30,"company":{"name":"Hatchtech","permalink":"hatchtech","image":{"available_sizes":[[[150,62],"assets/images/resized/0010/0196/100196v1-max-150x150.jpg"],[[233,97],"assets/images/resized/0010/0196/100196v1-max-250x250.jpg"],[[233,97],"assets/images/resized/0010/0196/100196v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.neurovista.com/docs/PR-NeuroVista_Equity_Financing.pdf","source_description":"NeuroVista Raises $16.5 Million in Equity Financing","raised_amount":16500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":18,"company":{"name":"NeuroVista","permalink":"neurovista","image":{"available_sizes":[[[150,56],"assets/images/resized/0008/0043/80043v1-max-150x150.jpg"],[[167,63],"assets/images/resized/0008/0043/80043v1-max-250x250.jpg"],[[167,63],"assets/images/resized/0008/0043/80043v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.nuontherapeutics.com/company/pr_2007-07-20.html","source_description":"Biotechnology Start-Up Nuon Therapeutics, Inc. Completes $5 Million Series A Financing And Names Management Team","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":7,"funded_day":20,"company":{"name":"Nuon Therapeutics","permalink":"nuon-therapeutics","image":{"available_sizes":[[[150,55],"assets/images/resized/0005/1236/51236v1-max-150x150.jpg"],[[240,88],"assets/images/resized/0005/1236/51236v1-max-250x250.jpg"],[[240,88],"assets/images/resized/0005/1236/51236v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.bizjournals.com/sanjose/stories/2010/08/09/daily62.html","source_description":"Nuon Therapeutics raises $10M in new funding","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":12,"company":{"name":"Nuon Therapeutics","permalink":"nuon-therapeutics","image":{"available_sizes":[[[150,55],"assets/images/resized/0005/1236/51236v1-max-150x150.jpg"],[[240,88],"assets/images/resized/0005/1236/51236v1-max-250x250.jpg"],[[240,88],"assets/images/resized/0005/1236/51236v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.bizjournals.com/sanjose/news/2011/03/02/airxpanders-raises-8m-in-third-round.html","source_description":"AirXpanders raises $8M in 2 financings","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":3,"funded_day":2,"company":{"name":"AirXpanders","permalink":"airxpanders","image":{"available_sizes":[[[150,35],"assets/images/resized/0008/5152/85152v1-max-150x150.jpg"],[[152,36],"assets/images/resized/0008/5152/85152v1-max-250x250.jpg"],[[152,36],"assets/images/resized/0008/5152/85152v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.masshightech.com/stories/2011/03/07/daily34-Euthymics-Bioscience-bumps-Series-A-to-28M.html","source_description":"Euthymics Bioscience bumps Series A to $28M","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":3,"funded_day":9,"company":{"name":"Euthymics Bioscience","permalink":"euthymics-bioscience","image":{"available_sizes":[[[150,42],"assets/images/resized/0009/4756/94756v1-max-150x150.png"],[[221,62],"assets/images/resized/0009/4756/94756v1-max-250x250.png"],[[221,62],"assets/images/resized/0009/4756/94756v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.pehub.com/102415/coda-therapeutics-inks-192m-series-b/","source_description":"CoDa Therapeutics Inks $19.2M Series B","raised_amount":19200000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":18,"company":{"name":"CoDa Therapeutics","permalink":"coda-therapeutics","image":{"available_sizes":[[[128,135],"assets/images/resized/0008/4437/84437v1-max-150x150.jpg"],[[128,135],"assets/images/resized/0008/4437/84437v1-max-250x250.jpg"],[[128,135],"assets/images/resized/0008/4437/84437v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://pathwaytx.com/reference/PR_June_18_2008.pdf","source_description":"$10million for Pathway cancer drugs","raised_amount":9600000,"raised_currency_code":"USD","funded_year":2008,"funded_month":6,"funded_day":18,"company":{"name":"Pathway Therapeutics","permalink":"pathway-therapeutics","image":{"available_sizes":[[[150,57],"assets/images/resized/0013/6498/136498v2-max-150x150.jpg"],[[250,96],"assets/images/resized/0013/6498/136498v2-max-250x250.jpg"],[[320,123],"assets/images/resized/0013/6498/136498v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://pathwaytx.com/reference/PR_Oct_9_2009.pdf","source_description":"Pathway Therapeutics Completes $3Million Financing for Cancer Programs and appoints Dr Julie Cherrington as Chief Executive Officer","raised_amount":2400000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":9,"company":{"name":"Pathway Therapeutics","permalink":"pathway-therapeutics","image":{"available_sizes":[[[150,57],"assets/images/resized/0013/6498/136498v2-max-150x150.jpg"],[[250,96],"assets/images/resized/0013/6498/136498v2-max-250x250.jpg"],[[320,123],"assets/images/resized/0013/6498/136498v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://pathwaytx.com/reference/PR_Aug_10_2010.pdf","source_description":"Pathway Therapeutics Completes $4.5 Million Financing for Novel PI3K Inhibitor Portfolio","raised_amount":4500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":10,"company":{"name":"Pathway Therapeutics","permalink":"pathway-therapeutics","image":{"available_sizes":[[[150,57],"assets/images/resized/0013/6498/136498v2-max-150x150.jpg"],[[250,96],"assets/images/resized/0013/6498/136498v2-max-250x250.jpg"],[[320,123],"assets/images/resized/0013/6498/136498v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://pathwaytx.com/reference/PR_%20May%2025%202011%20press%20release%20%20FINAL.pdf","source_description":"FDA Approves Trial of Pathway Therapeutics, Inc. Cancer Drug; $7.5 Million Financing in Place to Advance Novel PI3K/mTOR Inhibitor Portfolio","raised_amount":7500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":25,"company":{"name":"Pathway Therapeutics","permalink":"pathway-therapeutics","image":{"available_sizes":[[[150,57],"assets/images/resized/0013/6498/136498v2-max-150x150.jpg"],[[250,96],"assets/images/resized/0013/6498/136498v2-max-250x250.jpg"],[[320,123],"assets/images/resized/0013/6498/136498v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.spinifexpharma.com.au/news.htm","source_description":"Spinifex Closes AU$18.25M (~US$19M) Expanded Series B Round","raised_amount":19000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":23,"company":{"name":"Spinifex Pharmaceuticals","permalink":"spinifex-pharmaceuticals","image":{"available_sizes":[[[132,100],"assets/images/resized/0015/0803/150803v1-max-150x150.jpg"],[[132,100],"assets/images/resized/0015/0803/150803v1-max-250x250.jpg"],[[132,100],"assets/images/resized/0015/0803/150803v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/uptake-medical-inc-series-c-35m/","source_description":"Uptake Medical, Inc.: Series C $35M","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":10,"company":{"name":"Uptake Medical","permalink":"uptake-medical","image":{"available_sizes":[[[150,28],"assets/images/resized/0016/8280/168280v1-max-150x150.jpg"],[[250,47],"assets/images/resized/0016/8280/168280v1-max-250x250.jpg"],[[291,55],"assets/images/resized/0016/8280/168280v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.uptakemedical.com/uptake-medical-completes-series-b-financing-round-for-17-5-million","source_description":"Uptake Medical Completes Series B Financing Round for $17.5 Million","raised_amount":17500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":7,"company":{"name":"Uptake Medical","permalink":"uptake-medical","image":{"available_sizes":[[[150,28],"assets/images/resized/0016/8280/168280v1-max-150x150.jpg"],[[250,47],"assets/images/resized/0016/8280/168280v1-max-250x250.jpg"],[[291,55],"assets/images/resized/0016/8280/168280v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.airxpanders.com/2012/01/23/airxpanders-secures-10m-in-series-d-financing/","source_description":"AirXpanders Secures $10M in Series D Financing","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":23,"company":{"name":"AirXpanders","permalink":"airxpanders","image":{"available_sizes":[[[150,35],"assets/images/resized/0008/5152/85152v1-max-150x150.jpg"],[[152,36],"assets/images/resized/0008/5152/85152v1-max-250x250.jpg"],[[152,36],"assets/images/resized/0008/5152/85152v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/02/celladon-closes-43m-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Celladon Closes $43M in Funding","raised_amount":43000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":15,"company":{"name":"Celladon","permalink":"celladon","image":{"available_sizes":[[[150,19],"assets/images/resized/0006/4625/64625v1-max-150x150.jpg"],[[250,33],"assets/images/resized/0006/4625/64625v1-max-250x250.jpg"],[[338,45],"assets/images/resized/0006/4625/64625v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120501e851umngm&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120501e851umngm%26from%3dalert%26pid%3d32","source_description":"Hatchtech Appoints CEO, Closes On A$7.8M For Head Lice Treatment ","raised_amount":8100000,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":1,"company":{"name":"Hatchtech","permalink":"hatchtech","image":{"available_sizes":[[[150,62],"assets/images/resized/0010/0196/100196v1-max-150x150.jpg"],[[233,97],"assets/images/resized/0010/0196/100196v1-max-250x250.jpg"],[[233,97],"assets/images/resized/0010/0196/100196v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/07/coda-therapeutics-raises-20m-closes-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"CoDa Therapeutics Raises $20M in Second Closes Series B Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":24,"company":{"name":"CoDa Therapeutics","permalink":"coda-therapeutics","image":{"available_sizes":[[[128,135],"assets/images/resized/0008/4437/84437v1-max-150x150.jpg"],[[128,135],"assets/images/resized/0008/4437/84437v1-max-250x250.jpg"],[[128,135],"assets/images/resized/0008/4437/84437v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://finance.yahoo.com/news/neurovance-closes-7m-series-a1-113200571.html","source_description":"Neurovance Closes $7M Series A1 Round for Development of EB-1020 for ADHD; Reports Phase 1 Clinical Trial Results","raised_amount":7000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":18,"company":{"name":"Neurovance","permalink":"neurovance","image":null}}}],"milestones":[],"providerships":[],"funds":[{"name":"ABT","funded_year":1998,"funded_month":8,"funded_day":null,"raised_amount":42500000,"raised_currency_code":"USD","source_url":"","source_description":""}],"video_embeds":[],"external_links":[]}